INNPF
InnoCan Pharma Corporation
Set alert
1.29 USD 0.00 0.00%
1.29 Day range 1.29
1.25 52-week range 12.96
- YTD
- -82.16%
- 1 year
- -89.69%
- Open
- 1.29
- Prev close
- 1.29
- Mkt cap
- 5.80M
- Vol
- 100
- Avg vol
- 33
- EPS
- -0.26
- P/E
- 0.00
More statistics
- Low
- 1.29
- High
- 1.29
Financial health
Altman Z-Score
-1.02 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -28.9×
FY 2018 5y median -16.4× FY 2025
P/S 1.2×
FY 2018 5y median 5.5× FY 2025
P/B 5.8×
FY 2018 5y median 8.3× FY 2025
P/FCF 67.6×
FY 2018 5y median -19.0× FY 2025
EV/EBITDA 205×
FY 2018 5y median -17.5× FY 2025
EV/Sales 1.0×
FY 2018 5y median 5.2× FY 2025
FCF Yield 1.5%
FY 2018 5y median -4.8% FY 2025
Profitability
Gross Margin 89.9%
FY 2018 5y median 87.7% FY 2025
Operating Margin -4.7%
FY 2018 5y median -4.7% FY 2025
Net Margin -4.2%
FY 2018 5y median -34.4% FY 2025
ROE -20.1%
FY 2018 5y median -58.9% FY 2025
ROIC 54.9%
FY 2018 5y median 5.1% FY 2025
ROA -10.7%
FY 2018 5y median -54.0% FY 2025
Growth (YoY)
Revenue -9.6%
FY 2018 FY 2025
Operating Income -0.6%
FY 2018 FY 2025
EPS (diluted) 40.5%
FY 2018 FY 2025
Free Cash Flow 130.1%
FY 2018 FY 2025
Financial Health
Current Ratio 7.7×
FY 2018 5y median 4.1× FY 2025
Quick Ratio 6.1×
FY 2018 5y median 3.4× FY 2025
Debt / Equity 0.2×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA -44.3×
FY 2018 5y median 1.3× FY 2025
Interest Coverage -418×
FY 2018 5y median -418× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31